Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
07 October 2022
Closing Date:
19 October 2022
Location(s):
PL POLSKA (PL Poland/POLSKA)
Description:
Delivery of drugs in the drug program for the treatment of cystic fibrosis

The subject of the contract is: delivery of medicines in the drug program for the treatment of cystic fibrosis:

Package No. 1

1) Ivacaftorum 75mg + Tezacaftorum 50mg + Elexacaftorum 100mg x 56 tabletek (Kaftrio), 240 op.

2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 240 op.

Package No. 2

1) Tezacaftorum 50mg + Ivacaftorum 75 (Symkevi) x 28,18 op.

2) Ivacaftorum 75mg x 28 tabletek (Kalydeco), 18 op.

Package No. 3

1) Ivacaftorum 150mg x 56 tabletek (Kalydeco), 6 op.

The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".

The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.

Package No. 1

Package No. 1

1) Ivacaftorum 75mg + Tezacaftorum 50mg + Elexacaftorum 100mg x 56 tabletek (Kaftrio), 240 op.

2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 240 op.

Package No. 2

Package No. 2

1) Tezacaftorum 50mg + Ivacaftorum 75 (Symkevi) x 28,18 op.

2) Ivacaftorum 75mg x 28 tabletek (Kalydeco), 18 op.

Package No. 3

Package No. 3

1) Ivacaftorum 150mg x 56 tabletek (Kalydeco), 6 op.

Download full details as .pdf
The Buyer:
Instytut Gruźlicy i Chorób Płuc Oddział Terenowy im. Jana i Ireny Rudników w Rabce-Zdroju Instytut Badawczy
CPV Code(s):
33600000 - Pharmaceutical products